NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.11 -0.02 (-0.48 %)
(As of 04/23/2019 04:00 PM ET)
Previous Close$4.13
Today's Range$4.00 - $4.14
52-Week Range$2.31 - $5.14
Volume810,663 shs
Average Volume665,291 shs
Market Capitalization$328.65 million
P/E Ratio24.18
Dividend YieldN/A
Beta1.84
Neptune Wellness Solutions Inc., a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products. It develops turnkey nutrition product solutions in various delivery forms. The company offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.56 million
Cash Flow$0.2121 per share
Book Value$0.86 per share

Profitability

Net Income$13.67 million

Miscellaneous

Employees58
Market Cap$328.65 million
Next Earnings DateN/A
OptionableOptionable

Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) announced its earnings results on Wednesday, February, 13th. The biotechnology company reported ($0.04) earnings per share for the quarter. The biotechnology company had revenue of $4.95 million for the quarter. Neptune Wellness Solutions had a negative net margin of 60.48% and a negative return on equity of 18.85%. View Neptune Wellness Solutions' Earnings History.

What is the consensus analysts' recommendation for Neptune Wellness Solutions?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neptune Wellness Solutions.

Has Neptune Wellness Solutions been receiving favorable news coverage?

Media headlines about NEPT stock have been trending positive on Tuesday, InfoTrie reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of Neptune Wellness Solutions' key competitors?

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Cronos Group (CRON), Canopy Growth (CGC), Alibaba Group (BABA), Zynerba Pharmaceuticals (ZYNE), New Age Beverages (NBEV), Aurora Cannabis (ACB), Cara Therapeutics (CARA), Micron Technology (MU), Tilray (TLRY) and Aurora Cannabis (ACBFF).

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the folowing people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $4.11.

How big of a company is Neptune Wellness Solutions?

Neptune Wellness Solutions has a market capitalization of $328.65 million and generates $21.56 million in revenue each year. The biotechnology company earns $13.67 million in net income (profit) each year or $0.17 on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is http://neptunecorp.com.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]


MarketBeat Community Rating for Neptune Wellness Solutions (NASDAQ NEPT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  207
MarketBeat's community ratings are surveys of what our community members think about Neptune Wellness Solutions and other stocks. Vote "Outperform" if you believe NEPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by MarketBeat.com Staff

Featured Article: What is the Bid-Ask Spread?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel